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Background: Folate is an essential nutrient for cell survival and embryogenesis. 10-Formyltetrahydrofolate dehy-
drogenase (FDH) is the most abundant folate enzyme in folate-mediated one-carbon metabolism. 10-
Formyltetrahydrofolate dehydrogenase converts 10-formyltetrahydrofolate to tetrahydrofolate and CO2, the
only pathway responsible for formate oxidation in methanol intoxication. 10-Formyltetrahydrofolate
dehydrogenase has been considered a potential chemotherapeutic target because it was down-regulated in
cancer cells. However, the normal physiological signiﬁcance of 10-Formyltetrahydrofolate dehydrogenase is
not completely understood, hampering the development of therapeutic drug/regimen targeting 10-
Formyltetrahydrofolate dehydrogenase.
Methods: 10-Formyltetrahydrofolate dehydrogenase expression in zebraﬁsh embryos was knocked-down using
morpholino oligonucleotides. The morphological and biochemical characteristics of fdh morphants were exam-
ined using speciﬁc dye staining and whole-mount in-situ hybridization. Embryonic folate contents were deter-
mined by HPLC.
Results: The expression of 10-formyltetrahydrofolate dehydrogenase was consistent in whole embryos during
early embryogenesis and became tissue-speciﬁc in later stages. Knocking-down fdh impeded morphogenetic
movement and caused incorrect cardiac positioning, defective hematopoiesis, notochordmalformation and ulti-
mate death of morphants. Obstructed F-actin polymerization and delayed epiboly were observed in fdh
morphants. These abnormalities were reversed either by adding tetrahydrofolate or antioxidant or by co-
injecting the mRNA encoding 10-formyltetrahydrofolate dehydrogenase N-terminal domain, supporting the
anti-oxidative activity of 10-formyltetrahydrofolate dehydrogenase and the in vivo function of
tetrahydrofolate conservation for 10-formyltetrahydrofolate dehydrogenase N-terminal domain.
Conclusions: 10-Formyltetrahydrofolate dehydrogenase functioned in conserving the unstable tetrahydrofolate
and contributing to the intracellular anti-oxidative capacity of embryos, which was crucial in promoting proper
cell migration during embryogenesis.
General signiﬁcance: These newly reported tetrahydrofolate conserving and anti-oxidative activities of 10-
formyltetrahydrofolate dehydrogenase shall be important for unraveling 10-formyltetrahydrofolate
dehydrogenase biological signiﬁcance and the drug development targeting 10-formyltetrahydrofolate
dehydrogenase.© 2014 Elsevier B.V. All rights reserved.hydrogenase; THF, tetrahydrofolate; dpf, day-post-fertilization; hpf, hour-post-fertilization; MO, morpholino oligonucleotide;
FDH N-terminal domain
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Folate is a B vitamin essential for embryonic development and
heavily involved in the metabolism of many fundamental biomole-
cules, including purines, choline, amino acids, neurotransmitters and
S-adenosylmethionine (SAM), the major methyl donor for most intra-
cellular methylation reactions. Insufﬁcient folate has been associated
with many congenital anomalies including heart and neural tube de-
fects [1]. In cells, tetrahydrofolate carries a one-carbon unit at either
the N5 and/or N10 positions, forming different folate adducts. These fo-
late adducts participate in one-carbon metabolic (OCM) pathways and
are interconverted via several redox and synthetic reactions catalyzed
by several folate enzymes. Among all the folate enzymes participating
in this pathway, 10-formyltetrahydrofolate dehydrogenase (10-
formyltetrahydrofolate:NADP+ oxidoreductase; FDH or ALDH1L1;
E.C.1.5.1.6) is the most abundant one, comprising 1% of total soluble
protein in the rabbit liver [2]. FDH catalyzes the conversion of 10-
formyltetrahydrofolate (10-formyl-THF) to tetrahydrofolate (THF) and
CO2 (Eq. 1). Therefore, FDH was proposed to regulate the ratio of these
two major intracellular reduced folate pools.
Mammalian FDH is a homotetramer consisting of four identical
99 kD subunits. Each subunit is composed of a large C-terminal domain
and a small N-terminal domain connected by a linking peptide. The
proper alignment to bring both N- and C-terminal domains in a correct
orientation is required for 10-formyltetrahydrofolate dehydrogenase
activity [3]. The large C-terminal domain contains a NADP+ binding
site and has aldehyde dehydrogenase activity (Eq. 2) [2,4]. This alde-
hyde dehydrogenase activity was not found in zebraﬁsh FDH [5]. The
small N-terminal domain contains a 10-formyl-THF binding site and
catalyzes a 10-formyl-THF hydrolysis reaction (Eq. 3). The physiological
signiﬁcance of this hydrolase activity remains unclear. One proposal is
that this NADP+-independent hydrolase activity is to produce THF irre-
spective of the redox state (NADPH/NADP+ ratio) in the cell [6]. On the
N-terminal domain also resides a non-catalytic THF tight binding site,
which partially overlaps with the substrate catalytic site [7]. Currently,
the function of this non-catalytic site is unknown.
10‐formyl‐THFþ NADPþ→THFþ CO2 þ NADPH ð1Þ
Propanalþ NADPþ→propanoateþ NADPH ð2Þ
10‐formyl‐THF→THFþ formate ð3Þ
The physiological signiﬁcance of FDH is not completely understood.
The clinical importance of FDHwas ﬁrst recognized inmethanol detoxiﬁ-
cation, in which FDH is responsible for the ultimate removal of formate
[8]. However, this could not be considered an adequate reason for FDH
to exist in such a high quantity, leaving the biological signiﬁcance of
FDH under normal physiological conditions an unanswered question. Se-
questering unstable THF for storage and regulating free THF availability is
one of the functions postulated for FDH [9,10]. The speciﬁc expression of
FDH in the radial glia at the midline of neural tube during murine em-
bryogenesis suggested a role for FDH in neural tube formation, although
loss-of-function FDH mutations did not impair neural tube closure [11].
Homozygousmice lacking FDH appeared completely normal but exhibit-
ed a reproductive deﬁciency, which was attributed to a possible increase
of fetal lethality [12]. Recently, overexpressing FDH has been shown to
evoke metabolic stress and cause apoptosis in cancer cells, shedding
light on the possibility of FDH being a chemotherapeutic target [13–15].
Nevertheless, the biological signiﬁcance of FDH remains incompletely un-
derstood, especially under normal physiological condition, hampering
the development of therapeutic drug/regimen targeting FDH.
Zebraﬁsh has been a prominent vertebrate model for biological and
medical research. Considering its features of transparent embryos,external and rapid development and high throughput, zebraﬁsh could
serve as a valuable complementary in vivo platform for folate-related
studies. Several zebraﬁsh folate enzymes, including FDH, had been char-
acterized and shown to resemble mammalian orthologs, supporting the
use of zebraﬁsh to model folate-mediated one-carbon metabolism [5,
16–21]. In this study, we report the spatially speciﬁc but temporally con-
stant expression of FDH during embryogenesis.We examined the biolog-
ical signiﬁcance of FDH in develo\ping embryos using knock-down
strategies. The potential physiological function of FDH is also discussed.
2. Materials and methods
2.1. Materials
The SMART™ RACE ampliﬁcation kit was purchased from Clontech,
Inc. (California, US). Enzymes used for cloning were purchased from
New England BioLabs, Inc. (Maryland, US). The HPLC gel ﬁltration col-
umn Alltech ProSphere SEC, 250 HR, S-200 (4.6 mm × 30.0 cm) was
purchased from Alltech (Illinois, US). 10-Formyl-5,8-dideazafolate-ω-
Aminohexyl-Sepharose 4B afﬁnity column was prepared as previously
described [2]. Horseradish peroxidase-conjugated goat anti-rabbit IgG
secondary antibody was purchased from Santa Cruz Biotechnology Inc.
(California, US). Folates were generous gifts from Dr. Moser (Merck
Eprova AG, Switzerland). The AB strain zebraﬁsh embryo was a generous
gift from Dr. Hans Georg Frohnhöfer (Max-Planck-Institut für
Entwicklungsbiologie, Tübingen, Germany). The cRNA expression vector
pcGlobin2was a gift fromDr.Myungchull Rhee (ChungnamNationalUni-
versity, Daejeon, Korea). All other chemicals, including coenzymes,
buffers, amino acids, and antibiotics, were purchased from Sigma-
Aldrich Chemical Co. (Montana, US). The Escherichia coli strains and
vectors used for cloning and protein expression have been described pre-
viously [5].
2.2. Fish care and sample preparation forWestern blot and RT-PCR analysis
Zebraﬁsh (Danio rerio, AB strain) were bred and maintained in a 14–
10 h light–dark diurnal cycle following the standard procedure [22].
Embryos were staged according to Kimmel et al. [23]. The animal stud-
ies and all procedures for handling zebraﬁsh and embryos, including
breeding andmaintenance ofﬁsh and sample collection,were approved
by Afﬁdavit of Approval of Animal Use Protocol of National Cheng Kung
University (IACUC Approval NO. 96062). Embryos and tissues obtained
from adult zebraﬁshwere prepared forWestern blot analysis and RT-
PCR to determine cytosolic FDH (CFDH) levels and distribution as previ-
ously described [18]. The dominant yolk proteins in embryos before 24-
hpf were removed for Western blot analysis to avoid interference [24].
The puriﬁed rabbit anti-zebraﬁsh cytosolic FDH-N antibodywas used at
1:500 dilutions. Rabbit anti-actin antibody was used as a loading con-
trol. The primer pairs used for RT-PCR were as follows: 5′-CGCTGAGC
ATATGAGGGTGGTG-3′(forward) and 5′-GGTATAGACTGCTCCCGAG-
3′(reverse) for zebraﬁsh CFDH (570-bp fragment) and 5′-AGACATCA
AGGAGAAGCTGTG-3′(forward) and 5′-TCCAGACGGAGTATTTAC-3′(re-
verse) for β-actin (391-bp fragment) as a control for the RNA isolation
and reverse-transcription.
2.3. Whole mount F-actin staining
Embryos were ﬁxed overnight in 4% paraformaldehyde at 4 °C. Em-
bryos were washed in 0.1% PBSTx and dechorionated. They were then
incubated for 1 h in 0.5% PBSTx, followed by 4-hour incubation in
blocking buffer (PBS, 1% BSA, 10% goat serum, 1% DMSO, 0.1% Triton
X100). Embryoswere then incubated overnight at 4 °C in blocking solu-
tion containing phalloidin or primary antibody. Alexa 488 phalloidin
(molecular probe) was used at 1:400 dilutions. Images were observed
under a multi-photon confocal microscope (Olympus) and acquired
with the software FluoView FV1000.
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The sequences of MOs designed by the manufacturer (Gene-
Tools, LLC, Philomath, OR), based on the cfdh mRNA sequence we
provided, were: MO1 (5′-TCTTTGCACGTCCCAATAAGAGCCG-3′) and
MO2 (5′-TTCCTCTGCACGAAAGAAAGATTCA-3′) (Fig. S1). Complete
coding sequence or only N-terminus domain (amino acid 1–311) of
zebraﬁsh cytosolic FDH was cloned into pcGlibin2 by EcoRI restriction
enzyme sites [20]. The plasmid was linearized by XbaI and transcribed
in a reaction mixture containing T7 RNA polymerase (Roche), GpppG
cap analog (New England Biolabs), NTP and RNasin (Promega) at
37 °C for 2 h. The synthesized cfdh cRNAwas puriﬁed by phenol–chloro-
form extraction and quantiﬁed by absorbance at 260 nm on a Helios
spectrophotometer (Thermo). All reagents for microinjection, including
MO, capped-mRNA and folates, were dissolved in degassed and RNase
free Danieu's buffer to make proper stock solutions.
For microinjection, approximately 4.6 nl of solution containing MO,
capped-mRNA and/or folate was injected into embryos at the 1 to 4-cell
stages to reach the desired concentrations. For rescue experiments, em-
bryos were incubated in embryo's medium containing 0.25 mM THF or
20 μMN-acetyl-L-cysteine (NAC). Embryos injected with Danieu's buffer
and standard controlMO served as injection controls in each experiment.
Each experiment was repeated at least four times with approximately 50
embryos used for each group.
2.5. Whole-mount in situ hybridization (WISH)
WISH with digoxigenin (DIG)-labeled riboprobes was performed
following the protocol described by Jowett [25] and Thisse [26]. Ribo-
probes were generated by in vitro transcription in the presence of
digoxigenin-11-UTP from linearized templates. The probe used for fdh
was generated from a linearized plasmid containing the partial coding
sequences and 3′ UTR of zebraﬁsh fdh.
2.6. Folate detection
Individual folate adducts in embryos were measured following the
protocols as previously described [19]. In brief, approximately 50 embry-
oswere homogenized in 0.3ml of extraction buffer ﬂushedwith nitrogen
andheated in boilingwater for 5min before centrifugation. Conversion of
folyl polyglutamates in the supernatant to folate monoglutamates was
achieved by incubating the embryo extracts with 2 μg of puriﬁed recom-
binant zebraﬁsh gamma-glutamyl hydrolase and incubated at 37 °C for
5 min. After centrifugation and ﬁltration, 50 μl of the clear supernatant
was injected into an Aquasil C18 column on an HPLC system (Agilent
1100) for folate detection. The potential folate peaks in extracts were
identiﬁed by overlapping the retention times between the prospective
folate peaks and folate standards.
2.7. Hemoglobin
Embryonic hemoglobinwas visualized by incubating de-chorionated
embryos in O-dianisidine (0.6 mg/ml) solution in the dark for 15min as
previously described [27]. Presence of brown coloration indicates eryth-
rocytes containing hemoglobin (Hb). Embryos were post-ﬁxed in 4%
paraformaldehyde/PBS overnight at 4 °C and observed under light dis-
secting microscope.
2.8. Cell proliferation, apoptosis and neuromast staining
Cell proliferationwas evaluatedwith BrdU incorporation by incubat-
ing dechorionated embryos in 10mMBrdU solution at 16 °C for 30min
[28]. Apoptotic cells were visualized by incubating lived embryos in
1 μM YO-PRO-1 (Invitrogen/Molecular Probes, Eugene, OR) solution at
4 °C for 1 h in the dark and observed under aﬂuorescence dissectingmi-
croscope (excitation 491 nm, emission 509 nm) after a thorough wash[29]. Hair cells in lateral line neuromasts were labeled by incubating
embryos in 5 μM 4-(4-diethylaminostyryl)-N-methylpyridinium iodide
(4-Di-2-ASP) for 10 min and then observed under a ﬂuorescence
dissecting microscope (excitation 488 nm, emission 607 nm) after
being washed and anesthetized with tricaine.
2.9. Reactive oxygen species (ROS) assay
Reactive oxygen species (ROS) accumulation was assessed by incu-
bating dechorionated embryos in 100 μM solution of a non-ﬂuorescent
dye 2′,7′-dihydrodichloroﬂuorescein diacetate (H2DCFDA) for 30 min.
H2DCFDA was oxidized by ROS to generate dichloroﬂuorescein (DCF)
[30], whichwas ﬂuorescent and observed with a Leica Z16 APO ﬂuores-
cence dissecting microscope (excitation 485 nm, emission 560 nm).
2.10. Alcian blue cartilage staining
Embryos of 4 dpf were ﬁxed overnight in 4% paraformaldehyde at
4 °C. After being washed thoroughly in PBS then dehydrated gradually
in ethanol and embryos were stained in 0.1% Alcian blue solution (in
acetic acid) at room temperature overnight [31]. Embryos were rinsed
in 100% ethanol and serially rehydrated in PBS. Further translucentization
of the tissue was achieved by incubating embryos in 0.05% trypsin, 1%
KOH and 3% hydrogen peroxide solutions sequentially. Embryos were
washed in PBS and mounted in 80% glycetrol–2% KOH.
3. Results
3.1. Distribution of FDH was spatially dependent and tissue-speciﬁc
The distribution of FDH in adult zebraﬁsh was tissue speciﬁc in both
protein andmRNA levels. FDH was most abundant in the liver and then
in the GI and spinal cord of adult ﬁsh (Fig. 1A). In contrast, both fdh
mRNA and protein were equally distributed in embryos of all examined
stages during embryogenesis (Fig. 1B). The presence ofmRNA in embry-
os before 3 hpf implied a maternal deposition of maternal fdh mRNA
since the zygotic transcription did not begin until 3 hpf [32]. The results
of whole-mount in-situ hybridization (WISH) revealed a spatially and
temporally speciﬁc expression of fdh in early embryos. Fdh transcripts
were evenly distributed in embryonic epiblasts at 6 hpf but gradually
focused in the ﬂoor plate and head region, including eyes and mid-
hindbrain boundary, as embryogenesis proceeded (Fig. 1C). The fdh
signal was initially detected in polster, a tissue crucial for embryonic
patterning, and became abundant in somites and intermediate cell
mass (ICM) in 24 hpf embryos (Fig. 1C-b–f). Fdhwas expressed, appar-
ently and almost exclusively, in the embryonic liver and gastrointestinal
tract by 3 dpf (Fig. 1C-g). The expression of fdh was continuously
focused on the larval liver and digestive tract at least up to 5-dpf
(Fig. 1D). The agreement in the temporal and spatial distributions
between fdh expressed protein and mRNA levels indicates that tran-
scriptional regulation might contribute considerably to expressional
control. The constant expression of fdh during embryogenesis also
suggests a role for FDH in zebraﬁsh embryogenesis.
3.2. Fdh morphants exhibited defective embryogenesis
The strategy of using an antisensemorpholino oligonucleotide (MO)
to block gene translation has been widely used to determine gene func-
tion in vivo [33]. Two non-overlapping fdh-MOs, MO-1 andMO-2, were
injected into embryos at 1 to 2-cell stages and dose-dependently
decreased fdh protein translation (Supplement 1). Both MO-1 (9.6 ng)
and MO-2 (4.8 ng) exerted an approximately 40 to 60% decrease in
FDH protein level and caused comparable morphological abnormalities
in morphants (Fig. 2 and Supplement 1B). To avoid redundancy, only
the results of MO-2 were presented in the current report and described
as “MO” in the subsequent discussion unless otherwise indicated.
Fig. 1.Distributions of FDH in zebraﬁsh adult and embryos. Individual tissues of adult female zebraﬁsh (A) and embryos at the indicated stages (B)were subjected toWestern blot analysis
(top) and RT-PCR (bottom) for FDH distribution. 20 μg protein was used for each lane. Results presented are representative of seven independent repeats. (C) Embryos probing with fdh
anti-sense RNA forWISH revealed a homogenous distribution in embryos at 6 hpf and speciﬁc expression in neural tissues, somites, liver and GI, in embryos of later stages. (D) TheWISH
signals for fdhwere focused in the liver (arrow) andGI (arrowhead) of embryos at 4-dpf (l4 and d4) and 5-dpf (l5 and d5).Most embryos are shown in lateral viewwith anterior to the left
except in C—e, D—d4 and D—d5, which are shown in dorsal view. P, polster; FP, ﬂoor plate; GI, gastrointestinal tract; ICM, intermediate cell mass of mesoderm; MHB, mid–hindbrain
boundary.
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and served as the control for the knockdown procedure. Defective
embryonic development, includingmalformed heart and trunk,was ob-
served in embryos injected with fdh MOs (fdh morphants or
morphants) at 2 dpf and became increasingly evident at 3-dpf.
Morphants at 3 dpf were categorized into the groups of normal, mild
and severe based on the severity of gross morphological anomaly
(Fig. 2B). The quantiﬁcation for morphants in each group revealed sig-
niﬁcant impact to embryonic development. Morphants displayed a
thin and tubing heart accompanied by pericardial edema and lowered
heart rate, a shortened yolk extension, diminished circulating blood
cells, curved body with shortened trunk, atrophic tail and kinked noto-
chords (Fig. 2B and Supplements 2 and 3). Distorted heart with a tube-
shape suggested an unsuccessful looping, which was seen more clearly
in the fdhmorphant of Tg(cmlc2:egfp) embryoswith EGFP expression in
the myocardial cells [34]. Control embryos had completed the majority
of the heart looping process and possessed a compacted and functional
heart with a distinct ventricle and an atrium at 48 hpf (Fig. 2C). Howev-
er, the heart tube of fdh morphants remained in tube-shaped midline
structures, conﬁrming uncoupling of D-looping (the subsequent reposi-
tioning of the ventricle to the right of the atrium). Circulating blood cells
were signiﬁcantly decreased in more than 65% of fdh-morphants. The
interfered circulation was conﬁrmed by O-dianisidine staining for he-
moglobin, inwhich reducedhemoglobin signal and ectopic accumulation
of blood cells in extravascular tissues were observed (Fig. 2D). Smaller
head and eyes were also noticed, suggesting craniofacial malformation
in fdh morphants. Subsequent Alcian blue staining of 4 dpf fdh
morphants for larval cartilage revealed distorted Meckel's cartilages
and ceratohyal angle. The ceratobranchial cartilages in fdh morphants
were also disappeared, conﬁrming impeded craniofacial development
(Fig. 2E).To ensure the knockdown speciﬁcity, fdh mRNA and THF were co-
injected with MO for rescue (Fig. 2 and Supplements 2 to 7). Partial re-
versal in the severity of abnormal grossmorphologywas observed in fdh
mRNA (f-R) co-injected morphants. Successful heart looping and
increased heart rate were observed in the rescued embryos. Blood
cells re-appeared although extravascular blood cells accumulation oc-
curred occasionally due to the still-slower-than-normal heart rate. Un-
expectedly, co-injecting the mRNA encoding only the fdh N-terminal
domain (fN-R) also exerted an effective rescue (Fig. 2B). Exposing fdh
morphants to THF, the catalytic product of FDH, signiﬁcantly alleviated
the morphological abnormalities (Fig. 2, Supplements 5 to 6). Co-
injecting p53MO for suppressing non-speciﬁc knockdown off-target ef-
fects did not change the severity observed in fdh morphants (Supple-
ment 7). Our results suggested that fdh was crucial for embryonic
development.
3.3. Knocking-down FDH impeded the formation of various embryonic
tissues at early developmental stages
Fdhmorphants before 24 hpf were subjected toWISH and compared
with control embryos for tissue formation. Inmorphants, the expression
domain of ntl, which represents chordamesoderm (the notochord rudi-
ment) in the dorsal midline, was shorter andwider and failed to extend
to the anterior end of embryos, indicating an affected notochord (Fig. 3,
a–a2). The distortion of the notochord was more evident at the tail
region at 22 hpf (Fig. 3, b–b2). Mis-shaped neuroectoderm (krox20
and pax2.1) in the mid–hind brain boundary, optic vesicle and
rhombomeres with reduced signals also appeared (Fig. 3, c–c2, d–d2,
e–e2 and f–f2). Widened distance between bilateral adaxial cells, the
precursors to the embryonic slow muscle ﬁbers, was also obvious
when probed with the mesoderm marker (Fig. 3, g–g2 and h–h2).
Fig. 2. The impact of knocking-down fdh to zebraﬁsh embryonic development. Embryos at 1 to 4-cell stage were injected with 4.8 ng of scrambleMO or zebraﬁsh fdhMO andmonitored
for embryonic development at 3 dpf. (A) Embryos injected with scramble MO (control), fdhMO (MO), fdhMO plus 400 pg fdh full-length mRNA (MO+ f-R), fdhMO plus 400 pg fdh N-
terminal mRNA (MO+ fN-R) or fdhMO plus 5 pmol THF (MO+ THF) were examined for FDH protein level with Western blotting using anti-zebraﬁsh FDH N-ter antibody. (B) (upper)
Morphants were categorized into the categories of normal, mild and severe based on the severity of phenotypic abnormality: normal, embryos with correctly looped and functional heart
and straight body trunk; mild, embryos with pericardial edema and distorted heart chambers, lowered heart rate and/ormild curved trunk; severe, pericardial edemawith unsuccessfully
looped heart tube, signiﬁcantly decreased heart rate (b20 beats/min) and/or curved/shorten body trunk. Enlarged or tube-shaped cardiac chambers lacking ﬂowing blood cells (the inset
of higher magnitude with arrow) were often observed in morphants, especially in severe group. Abnormally accumulated blood cells in bulbus arteriosus (dotted arrow) and shortened
yolk extension (arrowhead) also appeared. Body curvature was evident in severe group. (lower) The percentages of embryos with the distinct phenotypes were quantiﬁed. Data were
reported in average of at least eight independently performedexperiments. Approximately 40–60 embryoswere included in each experiment for each group. (C) Tg(cmlc2-eGFP) embryos
injectedwith 4.8 ngMOexhibited unsuccessful looping of heart tube in comparison to control embryos. Ventral to dorsal view at 48 hpf. V, ventricle; A, atrium. B+F,merged image of both
bright and ﬂuorescent images. (D) Signiﬁcantly decreased signal of O-dianisidine staining in sinus venosus (arrow) and ectopic accumulation of red blood cells in peripheral extravascular
tissues (arrowhead)were observed in fdhmorphants (MO). (E)Morphants at 4 dpf were examined for their craniofacial structureswith Alcian blue staining. DistortedMeckel's cartilages
(double-headed arrow) and ceratohyal angle (dotted line) were apparent in fdh morphants, as well as the disappearance of ceratobranchial. Embryos are viewed from ventral to dorsal
with anterior to the left. The percentage of morphants displaying the presented phenotype is indicated at the lower-right corner. mc: Meckel's cartilage; ch: ceratohyal cartilage; cb,
ceratobranchial.
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rounded somites appeared in fdh morphants. These results indicated
that the axial tissues, including the axial and paraxial mesoderm, fail
to extend and converge properly in fdh morphants. The misplaced
cmlc2 signals in 24-hpf morphants were consistent with the defective
heart observed in 3 dpf morphants (Fig. 3i–i2). The lack of c-myb signal
in morphants at the posterior blood island, the caudal hematopoietic
tissues of zebraﬁsh embryos, also echoed the absence of circulating
blood cells observed in the heart of fdhmorphants at 3 dpf (Fig. 3j–j2).
These results showed that fdh knock-down profoundly impeded the or-
igin of embryonic tissues at rather early stages.
3.4. Reduced FDH expression impeded morphogenetic movement
The observation that knocking down fdh expression caused defects
in a wide-spectrum of tissues implied affected primordial neural crest
cells. Neural crest cells are a collection of cells that appears near the dor-
sal margins of the closing neural tube, which disperse throughout the
body of embryoswhere they give rise to a variety of structures includingthe teeth, bones, cartilage, skin, sensory capsules involving eyes and
other sense organs. Probing both control embryos and fdh morphants
of early stages with neural crest (NC) cell markers for WISH revealed
interfered NC cells patterning in morphants. Both control embryos and
fdh morphants displayed comparable signal intensities for NC cell
markers before 18 hpf except the slightly decreased Bmp 4 and msxE
at the polster (Fig. 4, a–a2 and b–b2). These results suggested that the
primordial induction and speciﬁcation for NC cells were mostly unaf-
fected at early embryonic stages. However, the patterning of NC cell
markers was altered. In comparison to control embryos, fdhmorphants
at 12 hpf displayed a widened space between the neural plate edges
stained by snai 1b and sox10 (Fig. 4, c–c2 and d–d2). In control embryos
at 16–18 hpf, sox10 positive NC cells migrated ventrally from the dorsal
aspect of the neural tube in bilateral streams to the otic vesicle and
the preotic and postotic clusters of glial precursors (Fig. 4f′, arrow-
head). However, those ventrally and bilaterally migratory NC cells
were not observed in fdh morphants. Instead, NC cells aggregated
at the dorsal midline (Fig. 4, f1 and f2, arrow). The expression of snai
1a, which is speciﬁc to segmental plate and tail bud, was comparable
Fig. 3. The effects of reduced fdh expression in embryonic tissue formation. Embryos of uninjected control (a–j) and those injectedwith 4.8 ng of fdhMO-1 (a1−j1) or fdhMO-2 (a2–j2) at
1 to 4-cell stageswere collected at indicated time and subjected toWISHwith probes speciﬁc for neural primodium (krox20: hindbrain rhombomeres; pax2.1: midbrain–hindbrain bound-
ary), notochord (ntl), somite (myoD), heart (cmlc2) and caudal hematopoietic tissue (c-myb). Presented here are the representatives of the abnormal morphology which were not
observed in control embryos butwere apparent inMO groups. The rate of occurrence for the abnormalmorphology ranged from 40% to 75%, depending on the probes used. nc, notochord;
hn, hindbrain neurons; MHB, midbrain–hindbrain boundary; OP: optic stalk; r2 and r4, hindbrain rhombomeres; s, somite; h, heart; PBI, posterior blood island.
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morphants. This observation indicated that embryos in both control and
morphant groups had reached similar developmental stages and the
anomalies observed in morphants should not be due to developmental
delay. Taken together, our results showed that reducing fdh expression
impeded NC cells patterning possibly by interfering NC cell migration.
3.5. Knocking down fdh expression impeded F-actin polymerization at the
blastoderm margin and caused epiboly delay
A shortened body axis is a hallmark of interfered epiboly. Epiboly is
themorphogeneticmovement of the blastoderm starting at late blastula
and followed by the conversion and extension of marginal blastomeres
during gastrulation. A delayed epiboly was observed in morphants be-
fore 15 hpf. This delaywas apparent as early as 7 hpf (onset of gastrula-
tion) and became increasingly evident by 9-hpf (late gastrulation)
(Fig. 5A). In control embryos, the blastoderm completely covered the
yolk cell and somites began to form by 11 hpf; whereas most fdh-morphants still remained at 90% epiboly or earlier, leaving an unclosed
yolk plug at the vegetal pole (Fig. 5A, b3 and c3). Co-injecting fdh-mRNA
partly reversed the delayed epiboly, conﬁrming the knockdown speci-
ﬁcity (Fig. 5B). Again, co-injecting fdh N-terminal domain mRNA effec-
tively reversed the delayed epiboly, suggesting that the N-terminal
domain of FDH has folded into a stable protein with a biological func-
tion. Incubating morphants in 0.25 mM THF slightly reversed the de-
layed epiboly although the rescuing effect was less signiﬁcant than
that of fdhmRNA co-injection. Our results showed that FDHwas crucial
for proper morphogenetic movement during zebraﬁsh gastrulation.
The movement of blastomeres in the enveloping layer (EVL) pro-
ceeds in the manner of collective cell migration and highly depends
on a functional cytoskeleton. Microﬁlament networks are enriched in
the cortex of EVL cells, which is especially apparent at the lamellipodial
extensions in the epiblasts at the margins approaching yolk syncytial
layer (YSL), and actively participates in early epiboly [35,36]. Fdh
morphants at 75% epiboly were stained in situ with ﬂuorescent
phalloidin, a high-afﬁnity probe speciﬁcally labeled F-actin. The actin-
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blasts along the EVL margin was clearly observed in control embryos;
whereas this actin-enriched boundary was signiﬁcantly diminished in
fdh morphants, suggesting a connection between the interfered F-
actin formation and delayed epiboly (Fig. 5C). The actin-enriched corti-
cal belt at the migrating EVL margin reappeared when morphants were
rescued with fdhmRNA, conﬁrming the causal effects of obstructed F-
actin formation to the delayed epiboly caused by fdh knockdown.
The development of posterior lateral lines (pLL), a sensory system of
teleost ﬁsh and amphibians, was signiﬁcantly impeded in fdhmorphants.
A posterior lateral line comprises a set of regularly spaced neuromasts ar-
ranged in line on thebody surface of zebraﬁsh and is closely related to our
auditory system. During embryogenesis, the neuromasts of pLL are de-
posited by proliferating and migrating primordial cells originating from
cephalic placodes along the horizontal myoseptum to the tip of the tail,
also in the manner resembling collective cell migration [37,38]. Embryos
at 3 dpf were stained with 4-Di-2-ASP, a dye speciﬁcally accumulating in
hair cells in neuromasts. The neuromasts in the posterior trunk of fdh
morphants were signiﬁcantly decreased in number or even completely
disappeared (Fig. 5D). The presence of ectopically located neuromasts
in fdh morphants indicated that the generation and differentiation of
neuromast cells in fdhmorphants were most likely intact, but the migra-
tory polarity of the cellswas lost. Again, co-injecting fdhmRNAor supple-
mented with THF reversed the disturbed neuromast distribution,
conﬁrming the speciﬁcity and causal effect of fdh knockdown to pLL
formation and embryonic primordial cell migration.
3.6. Knocking down fdh expression increased oxidative stress and activated
pERK in morphants
THF is the catalytic product of FDH and also a prominent intracellular
anti-oxidant [39,40]. Examining the oxidative stress in embryos of 9 hpf
and 24 hpf with DCFDA staining revealed an elevated ﬂuorescenceFig. 4. The effects of reduced FDH expression in neural crest cell distribution. Embryoswere exam
ment of neural crest cells and descendant tissues. Slightly decreased signal of bmp4, which label
tation period, was observed in both control embryos and morphants (a–a2). Reduced intensity
keel, neural plate, presumptive cephalic mesoderm, optic primordium and tail bud (b–b2). Emb
nial neural crest precursors in embryos at 12 hpf (c–c2) and themigratory neural crest cells (f′, a
(f–f2). f′, f1′ and f2′ show the enlarged lateral view of the boxed region in f, f1 and f2, respective
arrow). Snai 1b transcripts were observed in the otic vesicles, trigeminal ganglia (arrowhead)
conﬁrmed the comparable developmental stages between the compared embryos (e–e2). mb
tb, tail bud; ov, otic vesicle; *, anterior limit of cranial neural crest cells.intensity in morphants, as compared to control embryos (Fig. 6A). This
increased oxidative stress was alleviated by incubating morphants in
embryo water containing THF or anti-oxidant NAC. Incubating fdh
morphants in embryo water containing NAC also exerted rescuing
effects for the phenotypic anomalies observed at later stages (Figs. 5B,
D and 6B). Examining the folate content of fdhmorphantswith HPLC re-
vealed a 40% decrease of THF levels in morphants, which was partly re-
versed by simultaneously co-injecting fdh mRNA. These results
supported the causal effect of decreased THF to the elevated oxidative
stress due to fdh knockdown. Again, co-injecting fdh N-ter mRNA with
fdhMO also increased morphant THF level and reversed morphant ab-
normalities (Figs. 5 and 6). Injecting fdhmRNA alone to wild type em-
bryos caused no appreciable difference in gross morphology, but led
to an approximately 35% increase in THF level (Fig. 6C and Supplement
7). Curiously, altering fdh expression levels by either knockdown or
overexpression did not signiﬁcantly affect the embryonic 10-formyl-
THF level as compared with un-injected control embryos. Together,
these results indicated that it was the decreased THF level, but not 10-
formyl-THF, involved in the pathological mechanism in fdhmorphants.
Also, the N-terminal domain of FDH might possess biological activities
partly overlapping with full-length FDH in vivo.
Western blotting on the extracts prepared from 1 dpf morphants
revealed an increased level of phosphorylated ERK, suggesting the
involvement of ERK signaling in fdh knockdown-induced pathogenesis
(Fig. 6D). Adding THF and NAC reversed the increased phospho-ERK
level in fdhmorphants, implying that the ERK activationwas in response
to the oxidative stress induced by the decreased embryonic
THF. Also, adding U0126, a phosphor-ERK inhibitor, to embryonic
water reduced the severity of phenotypic abnormity observed in fdh
morphants (Fig. 6B). These results suggested that the ERK activation
in morphants was caused by the oxidative stress due to the decreased
THF and was at least partly responsible for the anomalies induced by
fdh-knockdown.inedwithWISH using probes speciﬁc for neural crest primordium to evaluate the evolve-
s polster (the hatching gland rudiment) underlying the forebrain during the early segmen-
was observed in morphants for msxE, the marker for ectoderm, midbrain neural rod and
ryos were shown in lateral viewwith anterior to the left. Sox10 labeled the primordial cra-
rrowhead), otic vesicle and the preotic andpostotic clusters of glial precursors at 16–18hpf
ly. Accumulation of neural crest cells inmidlinewas observed in fdhmorphants (f1 and f2,
(d–d2). The similar patterns of snai 1a signals observed between control and morphants
, midbrain; am, axial mesoderm ac, adaxial cells; upm, unsegmented paraxial mesoderm;
Fig. 5. Reduced fdh expression hindered epiboly and lateral line formation. (A) Embryos injected with fdhMO at 1 to 4-cell stages were examined for epibolic progression at indicated
stages. FDH morphants failed to close the yolk plug by 11 hpf. Arrows indicate the leading edge of migrating marginal blastomeres. (B) FDH morphants at 9 hpf were categorized into
normal (N90%), mild (75 to 90%) and severe (b75%) groups based on the degree of epiboly completed (left) and quantiﬁed (right). Co-injecting fdhmRNA or fdh N-ter-mRNA with fdh
MO partially rescued the delayed epiboly. Incubating morphants with 0.25 mM THF or 20 μM N-acetyl-L-cysteine (NAC) partially rescued delayed epiboly. For rescuing, morphants
were either co-injectedwith fdhmRNA (400 pg) or incubated inwater containing rescuing agents (0.25mMTHF or 20 μMN-acetyl-L-cysteine (NAC)) 2 h afterMO injection. (C) Embryos
at the stages of 65%–70% epibolywere ﬁxed, stainedwith rhodamine phalloidin for F-actin and imagedwith confocal microscope. Local actin recruitment in the yolk syncytial layer (white
arrow)was signiﬁcantly diminished in fdhmorphants; whereas clearly observed in control and RNA-rescuedmorphants. (D) Embryos injectedwith fdhMOwith/without rescuing agents
were characterized for lateral line formationwith 4-Di-2-ASP staining at 3-dpf and categorized into normal,mild and severe group based on the presence/absence andmigratory extent of
lateral line neuromasts (left). Displaced neuromasts (arrowhead) and lack of neuromast were often seen in fdhmorphants. Imageswere taken using Leica Z16 APO ﬂuorescence dissecting
microscope. Thepercentage of embryos in each phenotypic categorywas quantiﬁed for each experimental group (right).MO, fdhmorphants; L1–6: neuromasts lined up along theﬂanks of
embryos; ter: neuromasts clustered at the tail region; f-R, fdh full-length mRNA; fN-R, fdh N-terminal domain mRNA.
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FDH, themost abundant folate enzyme in the liver, has been consid-
ered a potential chemotherapeutic target. However, lacking the knowl-
edge on the biological signiﬁcance of FDH under normal physiological
conditions has hampered the development of anti-folate drug targeting
FDH. Here, we investigated the signiﬁcance of FDH in embryogenesis by
knocking down fdh expression in zebraﬁsh embryos. We showed that
decreasing fdh expression decreased the embryonic THF level and in-
creased oxidative stress, leading to impeded cell migration, delayed
epiboly, obstructed convergent extension and subsequently develop-
mental anomalies. The malformed notochord, somite and heart ob-
served in morphants (Figs. 2, 3 and 4) also supported the importance
of proper actin dynamic for the notochord and heart development [41,
42]. It should be noted that the fdh expression we knocked-down was
likely the cytosolic form of FDH, judging from the high similarity of its
primary structures and biochemical properties to those of mammalian
FDHs. The current studies provide in vivo evidence for the functions of
FDH in modulating folate pools and embryogenesis.
Our data suggested that the anti-oxidative activity of FDH was cru-
cial for embryogenesis. Previous studies suggested that FDH played a
role in embryonic development because fdh was expressed in the
post-natal and adult mice cerebellum [11,43]. We found that knockingdown fdh expression disturbed the development of various embryonic
tissues, including neural tissues, which was accompanied by decreased
BrdU incorporation and increased apoptotic signals (Supplement 8).
The C2 and C8 of 10-formyl-THF are required for purine de novo biosyn-
thesis. One would expect that the impact to embryogenesis caused by
increased or decreased FDH would be due to the effect to 10-formyl-
THF level. Unexpectedly, we found no appreciable change in embryonic
10-formyl-THF level when embryos were injected with either fdh
mRNA ormorpholino oligonucleotides. Instead, we detected ﬂuctuation
of THF levels in the wake of altered fdh expression. Previous studies
showed that in rapidly proliferating tumor cells FDH was down-
regulated. In contrast, in regenerating the liver, which was also full of
rapidly proliferating cells, FDH was highly expressed [44]. These data,
together with our observation that overexpressing FDH did not cause
obvious abnormality in embryos, suggested that theremight not be a di-
rect causal relationship between FDHexpression and nucleotide biosyn-
thesis in proliferating cells/tissues. Mechanisms besides disturbing
nucleotide biosynthesis may play a role in the obstructed embryogene-
sis observed in FDH morphants. Further studies showed that the in-
creased oxidative stress due to decreased THF level caused by fdh
knockdown contributed at least partly to the abnormality inmorphants.
Oxidative stress occurs when the steady-state balance between pro-
oxidants and anti-oxidants is changed. THF possesses anti-oxidative
Fig. 6.Knocking-down fdhexpression induced oxidative stress and ERK phosphorylation. (A) Control embryos and embryos injectedwith fdhMO(f-MO)were stainedwithDCFDA for ROS
detection at 9 hpf (upper) and 24 hpf (lower). THF, NAC and U0126, and a pERK inhibitor were added to embryowater 2 h afterMO injection and removed before DCFDA staining. (B) The
phenotypes of morphants with/without rescuing treatment at 1 dpf were categorized into normal, mild and severe groups based on the severity of morphological anomalies (left) and
quantiﬁed (right). (C) The content of THF and 10-formyl-THF in fdhmorphants with/without RNA rescue wasmeasuredwith HPLC and comparedwith control embryos. (D) Both control
embryos and fdhmorphants at 1 dpf were collected forWestern blotting to examine ERK expression and phosphorylation. Total embryos extract (40 μg)was loaded on each lane for SDS-
PAGE. MO, fdh-morphants; NAC, N-acetyl-cysteine; *, p b 0.05; **, p b 0.01 Statistic signiﬁcance was calculated with Student's t-test.
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39]. Increased FDH has been shown to help relieve oxidative stress-
induced by ethanol exposure [40]. The reversal of morphogenetic
abnormalities by adding THF or NAC conﬁrmed the causal effects of
oxidative stress in the fdh-knockdown induced pathogenesis and
further supported the signiﬁcance of the anti-oxidative activity provid-
ed by FDH during embryogenesis.
Although the physiological signiﬁcance of the FDH N-terminal do-
main hydrolase activity remains elusive wewere able to reverse the ab-
normalities of morphants by co-injecting the mRNA encoding only the
FDH N-terminal domain. Our results suggest that the function of the
FDH N-terminal domain maybe for maintaining the intracellular THF
level. 10-Formyl-THF dehydrogenase activity results in the reduction
of one-carbon units by generating carbon dioxide; whereas hydrolase
activity results in the storage of one-carbon units as formate. Therefore,
the signiﬁcance of FDH hydrolase activity, if it exists in vivo, would be
important since it would lead to the production of formate instead of
carbon dioxide. We have expressed, puriﬁed, crystallized and done
preliminary structural analysis of the zebraﬁsh N-terminal domain in
the presence of THF. There are at least two sites where THF is bound
(unpublished data).We are in the process of making sitemutants to de-
termine the possible catalytic site and the tight binding non-catalytic
site. These mutants will be tested to see if they still can partially restore
normal function in our fdh knock down mutants.
The constant level of 10-formyl-THF in embryos regardless of in-
creased or decreased fdh expression also suggests that other enzyme(s)or mechanism(s) might be responsible for maintaining a steady level of
10-formyl-THF in zebraﬁsh embryos. Curiously, this postulated mecha-
nism(s) seems to be lost in evolution since both decreased THF and in-
creased 10-formyl-THF were observed in the NEUT 2 mice lacking FDH
activity [12]. The question thus arises as what other mechanism guards
the intracellular 10-formyl-THF level and keeps it constant in zebraﬁsh
embryos, since altered FDH expression did not affect it. The activity
of 10-formyltetrahydrofolate synthase catalyzes the formation of
10-formylTHF from THF, ATP and formate. These two enzymes form a
“futile cycle” in cells. The importance of 10-formyltetrahydrofolate syn-
thase has been recently addressed in mouse models, in which impeded
pregnancy and embryogenesis occurred due to disturbed purine syn-
thesis in mice lacking 10-formyltetrahydrofolate synthase activi-
ty [45,46]. It shall be interesting and central to explore the possibility
of 10-formyltetrahydrofolate synthase acting in counterbalance of
FDH to maintain a constant intracellular 10-formyl-THF level.
Our results showed that fdh knockdown interfered with the later
stage of cardiac development. Distinct ventricle and atrium chambers
were observed inmorphants, indicating that the fusion of themyocardi-
al precursor and elongation of heart tube along the midline occurred
properly. However, the initial leftward placement of the elongated
heart tube and subsequent gradual bending at the atrioventricular
boundary was unsuccessful. Both severe pericardial edema and signiﬁ-
cantly slowed heart rate could be embryonic lethal if occurred in mam-
mals. Previous studies showed that homozygous NEUT2 mice lacking
FDH were viable, fertile and showed no increased incidence of neural
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(N200 days in NEUT2 mice vs. ~30 days in normal control). This repro-
ductive deﬁciency was attributed to increased fetal lethality probably
resulting from early arrest of fetal development after implantation
[12]. It should be noted that the impacts of a defective cardiac system
to the developing mouse embryos and to zebraﬁsh larvae shall be dis-
similar. A functional circulation system is indispensable for mammalian
embryonic development. Nevertheless, a functional circulation system
is not essential for zebraﬁsh larvae before 7 dpf since the transport of
nutrient and oxygen can be accomplished by diffusion. That means
thatmiscarriagewould occur tomost of themouse embryoswith defec-
tive hearts in very early stages of gestation, even before the awareness
of conception. Only very few embryos, probably with unidentiﬁed mu-
tation for adaption, could survive and be born. Contrarily, zebraﬁsh lar-
vaewith defective hearts could still survive for oneweek to be observed
and recorded. This was in agreement with the low survival rate (~10%)
observed in our fdh morphants (Figs. 2, 5 and 6) in which all those
morphants with either mild or severe phenotypic abnormalities were
dead by 1 week post fertilization. Our results provide a possible expla-
nation for the reproductive defect observed in the mice lacking active
FDH.
Disparities were found between our studies and other reports. We
showed that decreasing fdh expression impeded actin recruitment at
the migratory frontier of the enveloping layer in the blastoderm and
delayed epiboly progression. These results are in agreement with the
observation that disrupting actin-based structures led to the slowing
or immediate arrest of epiboly and support the importance of actin
dynamics within the YSL and EVL during embryogenesis [36]. They
also support the involvement of FDH in actin dynamic control. However,
it was the increase, instead of decrease, of FDH that inhibited actin
dynamic and cell mobility in human lung adenocarcinoma epithelial
cells [47]. Also, high levels of FDH exerted no harmful effect in zebraﬁsh
embryos and regenerating liver; whereas suppressor activity was re-
ported for FDH when overexpressed in cancer cells [15,44]. In addition,
we observed severely impeded embryonic development in fdh knock-
down embryos; whereas in a mouse model, lacking FDH activity did
not elicit obviousmorphological abnormality except extended breeding
time [12]. These differences probably reﬂect the divergence among dif-
ferent experimental platforms. They also imply that there exist distinct
functions and regulatory mechanisms for FDH in different tissues and
under different circumstances and that our understanding on the role
of FDH is incomplete. Further investigation on themechanisms underly-
ing these differences may help elucidate the conserved biological func-
tions of FDH during evolution and in disease pathogenic processes.
In the current study, we reported that pERK was activated in re-
sponse to the oxidative stress that resulted from decreased THF levels.
Previous studies showed that the binding of folic acid to folate receptors
on cell membrane inhibitedHUVEC proliferation via activating cSrc/ERK
2/NF-κB/p53 signaling pathway and inhibited cell migration through
inhibiting cSrc/p190RhoGAP-signaling pathway [48,49]. We do not
know whether the folic acid-induced inhibition on HUVEC migration
also involves intervention to one-carbonmetabolism since the intracel-
lular folate contents in those folic acid-exposed cells were not reported.
The questionwhether comparable or overlappingmechanisms occurred
in both fdh morphants and folic acid-treated cells warrants further
investigation.
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